AI for the prediction of early stages of Alzheimer's disease from neuroimaging biomarkers -- A narrative review of a growing field

• URL: http://arxiv.org/abs/2406.17822v1
• Date: Tue, 25 Jun 2024 09:22:53 GMT
• Title: AI for the prediction of early stages of Alzheimer's disease from neuroimaging biomarkers -- A narrative review of a growing field
• Authors: Thorsten Rudroff, Oona Rainio, Riku Klén,
• Abstract summary: Single-modality studies using structural MRI and PET imaging have demonstrated high accuracy in classifying AD. Multi-modality studies, integrating multiple neuroimaging techniques and biomarkers, have shown improved performance and robustness. challenges remain in data standardization, model interpretability, generalizability, clinical integration, and ethical considerations.
• Score: 0.0
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Objectives: The objectives of this narrative review are to summarize the current state of AI applications in neuroimaging for early Alzheimer's disease (AD) prediction and to highlight the potential of AI techniques in improving early AD diagnosis, prognosis, and management. Methods: We conducted a narrative review of studies using AI techniques applied to neuroimaging data for early AD prediction. We examined single-modality studies using structural MRI and PET imaging, as well as multi-modality studies integrating multiple neuroimaging techniques and biomarkers. Furthermore, they reviewed longitudinal studies that model AD progression and identify individuals at risk of rapid decline. Results: Single-modality studies using structural MRI and PET imaging have demonstrated high accuracy in classifying AD and predicting progression from mild cognitive impairment (MCI) to AD. Multi-modality studies, integrating multiple neuroimaging techniques and biomarkers, have shown improved performance and robustness compared to single-modality approaches. Longitudinal studies have highlighted the value of AI in modeling AD progression and identifying individuals at risk of rapid decline. However, challenges remain in data standardization, model interpretability, generalizability, clinical integration, and ethical considerations. Conclusion: AI techniques applied to neuroimaging data have the potential to improve early AD diagnosis, prognosis, and management. Addressing challenges related to data standardization, model interpretability, generalizability, clinical integration, and ethical considerations is crucial for realizing the full potential of AI in AD research and clinical practice. Collaborative efforts among researchers, clinicians, and regulatory agencies are needed to develop reliable, robust, and ethical AI tools that can benefit AD patients and society.

Related papers

• Advanced AI Framework for Enhanced Detection and Assessment of Abdominal Trauma: Integrating 3D Segmentation with 2D CNN and RNN Models [5.817643726988823]
  This study explores the application of artificial intelligence (AI) and machine learning (ML) to improve the speed and accuracy of abdominal trauma diagnosis. We developed an advanced AI-based model combining 3D segmentation, 2D Convolutional Neural Networks (CNN), and Recurrent Neural Networks (RNN) to enhance diagnostic performance. Our model processes abdominal CT scans to provide real-time, precise assessments, thereby improving clinical decision-making and patient outcomes.
  arXiv  Detail & Related papers  (2024-07-23T04:18:34Z)
• A Survey of Models for Cognitive Diagnosis: New Developments and Future Directions [66.40362209055023]
  This paper aims to provide a survey of current models for cognitive diagnosis, with more attention on new developments using machine learning-based methods. By comparing the model structures, parameter estimation algorithms, model evaluation methods and applications, we provide a relatively comprehensive review of the recent trends in cognitive diagnosis models.
  arXiv  Detail & Related papers  (2024-07-07T18:02:00Z)
• TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets [57.067409211231244]
  This paper presents meticulously curated AIready datasets covering multi-modal data (e.g., drug molecule, disease code, text, categorical/numerical features) and 8 crucial prediction challenges in clinical trial design. We provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design.
  arXiv  Detail & Related papers  (2024-06-30T09:13:10Z)
• A Survey of Artificial Intelligence in Gait-Based Neurodegenerative Disease Diagnosis [51.07114445705692]
  neurodegenerative diseases (NDs) traditionally require extensive healthcare resources and human effort for medical diagnosis and monitoring. As a crucial disease-related motor symptom, human gait can be exploited to characterize different NDs. The current advances in artificial intelligence (AI) models enable automatic gait analysis for NDs identification and classification.
  arXiv  Detail & Related papers  (2024-05-21T06:44:40Z)
• Enabling Collaborative Clinical Diagnosis of Infectious Keratitis by Integrating Expert Knowledge and Interpretable Data-driven Intelligence [28.144658552047975]
  This study investigates the performance, interpretability, and clinical utility of knowledge-guided diagnosis model (KGDM) in the diagnosis of infectious keratitis (IK) The diagnostic odds ratios (DOR) of the interpreted AI-based biomarkers are effective, ranging from 3.011 to 35.233. The participants with collaboration achieved a performance exceeding that of both humans and AI.
  arXiv  Detail & Related papers  (2024-01-14T02:10:54Z)
• Deployment of a Robust and Explainable Mortality Prediction Model: The COVID-19 Pandemic and Beyond [0.59374762912328]
  This study investigated the performance, explainability, and robustness of deployed artificial intelligence (AI) models in predicting mortality during the COVID-19 pandemic and beyond.
  arXiv  Detail & Related papers  (2023-11-28T18:15:53Z)
• Incomplete Multimodal Learning for Complex Brain Disorders Prediction [65.95783479249745]
  We propose a new incomplete multimodal data integration approach that employs transformers and generative adversarial networks. We apply our new method to predict cognitive degeneration and disease outcomes using the multimodal imaging genetic data from Alzheimer's Disease Neuroimaging Initiative cohort.
  arXiv  Detail & Related papers  (2023-05-25T16:29:16Z)
• GENIE-NF-AI: Identifying Neurofibromatosis Tumors using Liquid Neural Network (LTC) trained on AACR GENIE Datasets [0.0]
  We propose an interpretable AI approach to diagnose patients with neurofibromatosis. Our proposed approach outperformed existing models with 99.86% accuracy.
  arXiv  Detail & Related papers  (2023-04-26T10:28:59Z)
• Leveraging Pretrained Representations with Task-related Keywords for Alzheimer's Disease Detection [69.53626024091076]
  Alzheimer's disease (AD) is particularly prominent in older adults. Recent advances in pre-trained models motivate AD detection modeling to shift from low-level features to high-level representations. This paper presents several efficient methods to extract better AD-related cues from high-level acoustic and linguistic features.
  arXiv  Detail & Related papers  (2023-03-14T16:03:28Z)
• Neuro-symbolic Neurodegenerative Disease Modeling as Probabilistic Programmed Deep Kernels [93.58854458951431]
  We present a probabilistic programmed deep kernel learning approach to personalized, predictive modeling of neurodegenerative diseases. Our analysis considers a spectrum of neural and symbolic machine learning approaches. We run evaluations on the problem of Alzheimer's disease prediction, yielding results that surpass deep learning.
  arXiv  Detail & Related papers  (2020-09-16T15:16:03Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.